BSD acquires Duke hyperthermia license

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Hyperthermia cancer treatment device manufacturer BSD Medical reported that it has signed an exclusive patent license agreement with Duke University of Durham, N.C., for rights to Duke's treatment system for primary breast cancer using hyperthermia therapy.

The breast cancer treatment system has been used and tested at Duke University Medical Center over several years, according to the Salt Lake City-based company. BSD said it intends to integrate the technology with its current BSD-2000 and BSD-500 hyperthermia systems. The technology will be used to complement radiation therapy, chemotherapy, and heat released, targeted liposome drug delivery, BSD said.